Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Advanced fibrosis is not a negative pretreatment predictive factor for genotype 2 or 3 chronic hepatitis C patients

Hyun Seok Lee, Young Oh Kweon, Won Young Tak, Soo Young Park, Eun Jung Kang, Yu Lim Lee, Hae Min Yang, Hyun Woo Park

Clin Mol Hepatol. 2013;19(2):148-155. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.148

View: 7152 Download: 29 Crossref: 2

Case Report

Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B

Eun Hye Kim, Hana Park, Kun Ho Lee, Sang Hoon Ahn, Seung-Min Kim, Kwang-Hyub Han

Clin Mol Hepatol. 2013;19(1):82-86. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.82

View: 6825 Download: 84 Web of Science: 8 Crossref: 10

Original Article

High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice

Nae-Yun Heo, Young-Suk Lim, Han Chu Lee, Yung Sang Lee, Kang Mo Kim, Kwan Soo Byun, Kwang-Hyub Han, Kwan Sik Lee, Seung Woon Paik, Seung Kew Yoon, Dong Jin Suh

Clin Mol Hepatol. 2013;19(1):60-69. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.60

View: 8474 Download: 61 Web of Science: 6 Crossref: 7

A study of hepatitis B virus reactivation associated with rituximab therapy in real-world clinical practice: a single-center experience

Myung Jin Oh, Heon Ju Lee

Clin Mol Hepatol. 2013;19(1):51-59. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.51

View: 7499 Download: 79 Web of Science: 24 Crossref: 23

Clinical and epidemiological characteristics of Korean patients with hepatitis C virus genotype 6

Mun Hyuk Seong, Ho Kil, Jong Yeop Kim, Sang Soo Lee, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong, Young Seok Kim, Si Hyun Bae, Youn Jae Lee, Han Chu Lee, Haesun Yun, Byung Hak Kang, Kisang Kim

Clin Mol Hepatol. 2013;19(1):45-50. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.45

View: 7521 Download: 91 Crossref: 12

Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B

Mi Sung Park, Beom Kyung Kim, Kyung Sik Kim, Ja Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Oidov Baartarkhuu, Kwang Hyub Han, Chae Yoon Chon, Sang Hoon Ahn

Clin Mol Hepatol. 2013;19(1):29-35. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.29

View: 7561 Download: 54 Crossref: 11

Editorial

Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?

Young Kul Jung, Ju Hyun Kim

Clin Mol Hepatol. 2013;19(1):26-28. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.26

View: 6240 Download: 47 Crossref: 4

Review

Hepatitis C virus: virology and life cycle

Chang Wook Kim, Kyong-Mi Chang

Clin Mol Hepatol. 2013;19(1):17-25. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.17

View: 15796 Download: 383 Crossref: 96

Original Article

Multiplex polymerase chain reaction test for the diagnosis of acute viral hepatitis A

Nae-Yun Heo, Young-Suk Lim, Jihyun An, Sun-Young Ko, Heung-Bum Oh

Clin Mol Hepatol. 2012;18(4):397-403. Published online December 21, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.4.397

View: 7407 Download: 52 Crossref: 1

Efficacy of peginterferon and ribavirin is associated with the IL28B gene in Korean patients with chronic hepatitis C

Seok Hoo Jeong, Young Kul Jung, Jae Won Yang, Sang Jin Park, Jong Woo Kim, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim

Clin Mol Hepatol. 2012;18(4):360-367. Published online December 21, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.4.360

View: 7444 Download: 32 Crossref: 13

Review

Hepatitis C virus and hepatocarcinogenesis

Soung Won Jeong, Jae Young Jang, Raymond T. Chung

Clin Mol Hepatol. 2012;18(4):347-356. Published online December 21, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.4.347

View: 13601 Download: 131 Crossref: 66

Original Article

Association between apolipoprotein E genotype, chronic liver disease, and hepatitis B virus

Seun Joo Ahn, Dong Kyu Kim, Soon Sun Kim, Chang Bum Bae, Hyo Jung Cho, Han Gyeol Kim, Young Jip Kim, Joo Ho Lee, Hyo Jin Lee, Mi Yeon Lee, Kee Bum Kim, Jin Hee Cho, Sung Won Cho, Jae Youn Cheong

Clin Mol Hepatol. 2012;18(3):295-301. Published online September 25, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.3.295

View: 8253 Download: 67 Crossref: 16

A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C

Byung Chul You, Young Seok Kim, Hun il Kim, Se Hun Kim, Seung Sik Park, Yu Ri Seo, Sang Gyune Kim, Se Whan Lee, Hong Soo Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim

Clin Mol Hepatol. 2012;18(3):272-278. Published online September 25, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.3.272

View: 7309 Download: 38 Crossref: 1

Editorial

Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients

Woo Jin Chung

Clin Mol Hepatol. 2012;18(3):268-271. Published online September 25, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.3.268

View: 5639 Download: 45 Crossref: 1

Case Report

A fatal case of hepatitis B virus (HBV) reactivation during long-term, very-low-dose steroid treatment in an inactive HBV carrier

Joong Ho Bae, Joo Hyun Sohn, Hye Soon Lee, Hye Sun Park, Yil Sik Hyun, Tae Yeob Kim, Chang Soo Eun, Yong Cheol Jeon, Dong Soo Han

Clin Mol Hepatol. 2012;18(2):225-228. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.225

View: 8412 Download: 89 Crossref: 17

Original Article

Hepatitis C virus (HCV) genotypes and the influence of HCV subtype 1b on the progression of chronic hepatitis C in Korea: a single center experience

Eun Ju Cho, Su Hyeon Jeong, Byung Hoon Han, Sang Uk Lee, Byung Chul Yun, Eun Taek Park

Clin Mol Hepatol. 2012;18(2):219-224. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.219

View: 7221 Download: 52 Crossref: 24

Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naïve patients with chronic hepatitis B infection

Won Gil Chung, Hong Joo Kim, Young Gil Choe, Hyo Sun Seok, Chang Wook Chon, Yong Kyun Cho, Byung Ik Kim, Young Yool Koh

Clin Mol Hepatol. 2012;18(2):195-202. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.195

View: 9139 Download: 71 Crossref: 12

Comparison of usefulness of clinical diagnostic criteria for hepatocellular carcinoma in a hepatitis B endemic area

So Young Bae, Moon Seok Choi, Geum-Youn Gwak, Yong Han Paik, Joon Hyoek Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo

Clin Mol Hepatol. 2012;18(2):185-194. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.185

View: 6948 Download: 72 Crossref: 6

Review

KASL Clinical Practice Guidelines: Management of chronic hepatitis B

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2012;18(2):109-162. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.109

View: 15144 Download: 109 Crossref: 118

Viewed By 5688	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4951	MAFLD: How is it different from NAFLD?
Viewed By 4719	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3826	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3813	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 135	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 80	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Viral hepatitis